Equities

Resonate Blends Inc

KOAN:PKC

Resonate Blends Inc

Actions
  • Price (USD)0.01
  • Today's Change0.002 / 23.46%
  • Shares traded10.00k
  • 1 Year change-83.36%
  • Beta2.9285
Data delayed at least 15 minutes, as of Sep 20 2024 20:38 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Resonate Blends, Inc. is a cannabis holding company. The Company, through its subsidiary, Resonate Blends LLC, offers wellness and lifestyle brands, which are built on a system of experiential targets. The Company’s products include Calm, Wonder, Love, Create, Play, Delight and Sleep. Its products are emulsified, water-soluble, single-dose formulas that can be used privately or shared socially. These products can be taken directly from the bottle or poured into beverages. Its Calm product consists of Cannabidiol (CBD) along with Tetrahydrocannabinol (THC). Its Wonder product consists of THC. Its Create product is formulated with a blend of terpenes and THC. Its Play product helps people to become fully immersed in the moment and the people around them. The Company also operates an intellectual property (IP) subsidiary, namely Entourage Labs LLC.

  • Revenue in USD (TTM)751.28k
  • Net income in USD-1.88m
  • Incorporated2013
  • Employees6.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pure Harvest Corporate Group Inc2.48m-6.67m175.36k25.00--0.0876--0.0708-0.0901-0.09010.03830.02010.26441.4640.6499,070.40-70.96---136.76--33.83---268.37--0.5886-0.8660.7639--1,808.41---459.26------
Life Stem Genetics Inc0.00-568.02k393.34k1.00--0.21-----0.013-0.0130.000.00760.00----0.00-198.83---330.32--------------0.0241--------------
ITonis Inc0.00-1.17m609.36k-----------0.0012-0.00120.00-0.00040.00-------187.63---1,169.36-------------0.8999---------506.86------
TRACON Pharmaceuticals Inc3.20m5.20m707.07k17.000.0547--0.13570.2213.793.791.39-0.90650.3267----188,235.3053.04-79.42---177.85----162.34-813.81---19.35------32.0587.68------
Resonate Blends Inc751.28k-1.88m797.05k6.00------1.06-0.0205-0.02050.0083-0.02440.632--11.93---158.40-680.29----46.92-78.88-250.64-12,895.26---2.304.00---66.73-56.57-316.63------
PainReform Ltd0.00-17.67m881.21k6.00---------41.92-41.920.00-3.530.00----0.00-309.43-55.47-650.22-68.20---------------------6.28------
Agentix Corp0.00-585.16k906.02k-----------0.0146-0.01460.00-0.06390.00-------318.23-----------------19.24--------57.41------
Bespoke Extracts Inc956.86k-1.36m966.01k10.00------1.01-0.1331-0.13310.0941-0.1942.2920.1021.3695,686.00-325.13------45.50---141.75--0.0482-53.38----22,933.72--63.98------
Evofem Biosciences Inc17.71m57.36m973.19k37.000.0007--0.01690.0549-0.4918-0.49180.0297-0.78031.571.813.61478,756.80534.21-211.64----75.75--341.16-1,031.550.0841-4.50----8.20--164.08---10.59--
CanaQuest Medical Corp0.00-812.13k1.05m-----------0.0517-0.05170.00-0.03720.00-------1,084.38--------------------------57.42------
Data as of Sep 20 2024. Currency figures normalised to Resonate Blends Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.